Search Results - Abdelmooti, Mohamed

  • Showing 1 - 7 results of 7
Refine Results
  1. 1
    Pulmonary Complications in Egyptian Bone Marrow Transplantation Recipients and their Effect on the Outcome of Transplant: A Single Center Experience

    Pulmonary Complications in Egyptian Bone Marrow Transplantation Recipients and their Effect on the Outcome of Transplant: A Single Center Experience by Al-Abbassy, Yasmin Fahd, Ahmed, Mona Mansour, Samra, Mohamed Abdelmooti Mohamed, Ali Abd El-Haleem, Tamer Mohamed, El-Kader, Maryam Ali Abd

    Get full text
    Article
    Save to List
    Saved in:
  2. 2
    HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND SOLUTIONS

    HEMATOPOIETIC STEM CELL TRANSPLANTATION IN EGYPT CHALLENGES AND SOLUTIONS by Mahmoud, Hossam Kamel, Fathy, Gamaleldin Mohamed, Elhaddad, Alaa, Fahmy, Omar Abdelrahman, Abdelmooti, Mohamed, Abdelfattah, Raafat, Bokhary, Mahmoud Tarek Sayed Ahmed

    Get full text
    Items that cite this one
    Article
    Save to List
    Saved in:
  3. 3
    Poster: CT-132 Outcome of Sex-Mismatched Allogeneic Hemopoietic Stem Cell Transplantation from Human Leukocyte Antigen–Identical Sibling Donors in Patients With Hematologic Diseases

    Poster: CT-132 Outcome of Sex-Mismatched Allogeneic Hemopoietic Stem Cell Transplantation from Human Leukocyte Antigen–Identical Sibling Donors in Patients With Hematologic Disease... by Bokhary, Mahmoud, Kamel, Rasha, Fathy, Gamal, Abdelmooti, Mohamed, Abdelfattah, Raafat, Fahmy, Omar, Elhaddad, Alaa, Azzazy, Mohamed, Mahmoud, Hossam

    Get full text
    Article
    Save to List
    Saved in:
  4. 4
    CT-132 Outcome of Sex-Mismatched Allogeneic Hemopoietic Stem Cell Transplantation from Human Leukocyte Antigen–Identical Sibling Donors in Patients With Hematologic Diseases

    CT-132 Outcome of Sex-Mismatched Allogeneic Hemopoietic Stem Cell Transplantation from Human Leukocyte Antigen–Identical Sibling Donors in Patients With Hematologic Diseases by Bokhary, Mahmoud, Kamel, Rasha, Fathy, Gamal, Abdelmooti, Mohamed, Abdelfattah, Raafat, Fahmy, Omar, Elhaddad, Alaa, Azzazy, Mohamed, Mahmoud, Hossam

    Get full text
    Article
    Save to List
    Saved in:
  5. 5
    With the Financial Toxicity and Other Adverse Events of 2G TKI, Is Imatinib Still a Valid Option in Higher-Risk Young Patients with Newly Diagnosed Chronic-Phase CML?

    With the Financial Toxicity and Other Adverse Events of 2G TKI, Is Imatinib Still a Valid Option in Higher-Risk Young Patients with Newly Diagnosed Chronic-Phase CML? by Maher, Mohamed, Abdelmooti Samra, Mohamed, Abdelfattah, Raafat M., ElGammal, Mosaad M., Kamel, Hossam M.

    Get full text
    Article
    Save to List
    Saved in:
  6. 6
    CML-137 With the Financial Toxicity and Other Adverse Events of 2G TKI, Is Imatinib Still a Valid Option in Higher-Risk Young Patients with Newly Diagnosed Chronic-Phase CML?

    CML-137 With the Financial Toxicity and Other Adverse Events of 2G TKI, Is Imatinib Still a Valid Option in Higher-Risk Young Patients with Newly Diagnosed Chronic-Phase CML? by Maher, Mohamed, Abdelmooti Samra, Mohamed, Abdelfattah, Raafat M., ElGammal, Mosaad M., Kamel, Hossam M.

    Get full text
    Article
    Save to List
    Saved in:
  7. 7
    Polymorphisms of xeroderma pigmentosum genes (XPC, XPD, and XPG) and susceptibility to acute leukemia among a sample of Egyptian patients

    Polymorphisms of xeroderma pigmentosum genes (XPC, XPD, and XPG) and susceptibility to acute leukemia among a sample of Egyptian patients by ElMahgoub, Iman Rifaat, Gouda, Heba Mahmoud, Samra, Mohamed Abdelmooti, Shaheen, Iman AbdelMohsen, ElMaraashly, Aya Hassan

    Get full text
    Items that this one cites
    Items that cite this one
    Article
    Save to List
    Saved in:

Search Tools: